Only logged in customers who have purchased this product may leave a review.
Bronchogen 20mg
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 20mg
R799,00
Chemical Name / Amino Acid Sequence: Ala-Glu-Asp-Leu
Availability: In stock
SKU: BR20
Bronchogen 20mg
R799,00
Bronchogen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Leu; AEDL) investigated for its potential role in respiratory tissue biology, epithelial regeneration and healthy ageing.
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About Bronchogen 20mg
Bronchogen belongs to the Khavinson peptide bioregulator family. Experimental studies have explored its effects on gene expression, bronchial epithelial cell function and respiratory tissue homeostasis.
How It Works in Research
Preclinical studies suggest Bronchogen may influence gene expression through interactions with chromatin and regulatory proteins. Research has investigated its potential effects on bronchial epithelial cell maintenance, tissue regeneration and respiratory cellular homeostasis.
Research Applications
Add product-specific research application content using the custom field: pl_who_is_it_for.
Researchers investigate Bronchogen because it may help support normal respiratory tissue function through peptide bioregulation and cellular regulation.
Product Specifications
- Product Name: Bronchogen
- Alternate Chemical Name: Ala-Glu-Asp-Leu (AEDL)
- Amino Acid Sequence: Ala-Glu-Asp-Leu
- Reference Strength: 20 mg
Research Information
- Appearance: White to off-white lyophilised powder
- Purity Standard: ≥98% (HPLC)
- Category: Tetrapeptide Bioregulator
- Reconstitution: 3.0 mL bacteriostatic water
- Final Concentration: 6.67 mg/mL
- Storage: 2–8°C after reconstitution
Mechanism of Action
Preclinical studies suggest Bronchogen may influence gene expression through interactions with chromatin and regulatory proteins. Research has investigated its potential effects on bronchial epithelial cell maintenance, tissue regeneration and respiratory cellular homeostasis.
Potential Benefits in Research
May support bronchial epithelial cell health.
- May promote respiratory tissue maintenance.
- May support cellular repair processes.
- May influence gene expression involved in tissue homeostasis.
- Potential support for healthy ageing through peptide bioregulation.
Safety Profile
No published human clinical dosing studies are available.
- Mild injection-site irritation may occur.
- Long-term human safety has not been established.
- Most available evidence is from laboratory and animal research.
This protocol is an educational research framework and not an established human clinical dosing regimen.
REFERENCE RECONSTITUTION INFORMATION
Goal: Support respiratory tissue health and cellular regeneration in research settings. Schedule: Once daily, 5 days on / 2 days off. Cycle Length: 8–12 weeks (optional extension to 16 weeks). Dose Range: 0.5–2.0 mg daily. Reconstitution: Add 3.0 mL bacteriostatic water to one 20 mg vial (6.67 mg/mL).
Always follow sterile preparation techniques when handling research peptides.
This protocol is an educational research framework and not an established human clinical dosing regimen.
General Preparation
• Use a new sterile syringe for each injection. • Rotate injection sites. • Store refrigerated after reconstitution. • This protocol is an educational research framework and not an established human clinical dosing regimen.
- Slowly add bacteriostatic water down the inside wall of the vial. Allow the powder to dissolve naturally and gently swirl until clear. Do not shake vigorously.
BRONCHOGEN (20MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of Bronchogen 20mg.
- Schedule: Once daily, 5 days on / 2 days off.
- Cycle Length: 8–12 weeks (optional extension to 16 weeks).
- Dose Range: 0.5–2.0 mg daily.
Reference Parameters (Dosing Protocol)
| Week | Daily Dose (mg) | U-100 Units | Volume |
|---|---|---|---|
| Weeks 1–2 | 0.5 mg | 7.5 units | 0.075 mL |
| Weeks 3–4 | 1.0 mg | 15 units | 0.15 mL |
| Weeks 5–6 | 1.5 mg | 22.5 units | 0.225 mL |
| Weeks 7–12 | 2.0 mg | 30 units | 0.30 mL |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
8–12 weeks (optional extension to 16 weeks).
RESEARCH CONTEXT
Support respiratory tissue health and cellular regeneration in research settings.
Once daily, 5 days on / 2 days off.
View Certificate of Analysis
View Certificate of Analysis Each batch of Bronchogen is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99.6%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Related products
-
Metabolic Research
Retatrutide
Price range: R899,00 through R1999,00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.